Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed6
Recruiting2
Other1

Role Distribution

Principal Investigator9
PI Rate100%

Activity Timeline

Clinical Trials (9)

NCT05457790Not ApplicableSuspended
Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD)
Chronic InsomniaInsomniaNonorganic Insomnia+4 more
PrincipalinvestigatorStart date: 2024-05-03
NCT05361811Not ApplicableRecruiting
Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial
Cardiofaciocutaneous SyndromeCostello SyndromeLegius Syndrome+2 more
PrincipalinvestigatorStart date: 2024-01-10
NCT03531814Not ApplicableCompleted
Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials
Neurofibroma, PlexiformNeurofibromatosis 1
PrincipalinvestigatorStart date: 2018-10-23
NCT02471339Phase 3Completed
Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain
Neurofibromatosis Type 1Plexiform Neurofibromas
PrincipalinvestigatorStart date: 2015-07-07
NCT01639950Completed
Validating Pain Scales in Children and Young Adults
LeukemiaNeurofibromatosisSickle Cell Disease+1 more
PrincipalinvestigatorStart date: 2012-08-06

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Neurofibromatosis 1Neurofibroma, PlexiformSarcoma+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

LeukemiaSarcomaSolid Tumor

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Brain CancerSarcoma
Similarity Score3%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Brain CancerGlioblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LeukemiaAnemia, Sickle Cell

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Ana-Maria Vranceanu, PhD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

NeurofibromatosesNeurofibromatosis 1
Similarity Score3%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

SarcomaSolid Tumor
Similarity Score3%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

GlioblastomaSarcoma
Similarity Score3%

Mike Royal, MD

Sorrento Therapeutics, Inc.

Related
19 trials

Shared therapeutic areas:

Solid TumorSarcoma
Similarity Score3%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Leukemia
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (9)

Showing 9 of 9 trials

NCT06880991PrincipalInvestigator

Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study

NeurofibromaNeurofibromatosis Type 1
Recruiting
NCT05457790Not ApplicablePrincipalInvestigator

Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD)

Chronic InsomniaInsomniaNonorganic Insomnia+4 more
Suspended
NCT05361811Not ApplicablePrincipalInvestigator

Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

Cardiofaciocutaneous SyndromeCostello SyndromeLegius Syndrome+2 more
Recruiting
NCT03538587Not ApplicablePrincipalInvestigator

Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers

AstrocytomaBrain CancerGlioblastomas+2 more
Completed
NCT03531814Not ApplicablePrincipalInvestigator

Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials

Neurofibroma, PlexiformNeurofibromatosis 1
Completed
NCT02471339Phase 3PrincipalInvestigator

Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain

Neurofibromatosis Type 1Plexiform Neurofibromas
Completed
NCT01639950PrincipalInvestigator

Validating Pain Scales in Children and Young Adults

LeukemiaNeurofibromatosisSickle Cell Disease+1 more
Completed
NCT01633008Early Phase 1PrincipalInvestigator

Acceptance and Commitment Therapy for Adolescents and Young Adults With Neurofibromatosis and Chronic Pain

Neurofibromatosis
Completed
NCT02153931PrincipalInvestigator

Internet Support Group for Parents of a Child With Neurofibromatosis Type 1

Neurofibromatosis 1
Completed

All 9 trials loaded